X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives

By Hannah Mooney  |    November 14, 2016
Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the...   Read More

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

By Hannah Mooney  |    September 12, 2016
Currently, more than 23.5 million Americans are affected by one of the more than 80 autoimmune diseases identified to date. These diseases range in severity, with their own characteristics and...   Read More

Patients showcase longer, healthier lives in new “From Hope to Cures” ads

By Ieva M. Augstums  |    September 6, 2016
For Ed, a longer life meant more time with family, friends and his dog, BearBear. When he was diagnosed with colon cancer, he underwent six weeks of radiation, seven months of chemotherapy and 10...   Read More

Science of Hope: Learning from setbacks

By Andrew Powaleny  |    June 20, 2016
America’s biopharmaceutical research companies are committed to developing new treatments and cures that improve health and save patient lives. Jen O’Neil, principal oncology scientist at Merck,...   Read More

America’s biopharmaceutical researchers advance the science of hope in new “From Hope to Cures” ads

By Ieva M. Augstums  |    June 14, 2016
Jen and Yingzi are in the problem-solving business. Every day, they tackle one of the toughest health care problems: cancer. While many others like them across the biopharmaceutical industry work...   Read More

Matt and Jamie share their stories in new “From Hope to Cures” ads

By Ieva M. Augstums  |    April 18, 2016
For Matt, today is a great day to be alive. And if you ask him why today is possible for him and why tomorrow is possible, too, he will tell you: Innovative medicines saved his life. When he was...   Read More

Fighting blood cancers together at the 2016 Leukemia Ball

By Josephine Martin  |    March 11, 2016
Tomorrow, the Leukemia & Lymphoma Society (LLS) will hold one of Washington, D.C.’s largest charitable events: the 2016 Leukemia Ball. Since it began in 1988, the annual event has raised nearly...   Read More

Patients and researchers say “we’re fighting back” in new “From Hope to Cures” ads

By Ieva M. Augstums  |    February 8, 2016
Diagnosed with type 1 diabetes at a young age, five-year-old Rhys has not let his diagnosis be his destiny. He enjoys life to the fullest, from playing sports to having treats at a friend’s...   Read More

Join “I’m Not Average,” a community for patients and supporters

By Ieva M. Augstums  |    December 15, 2015
Every patient has a story. This is the core belief that inspired the creation of “I’m Not Average,” an online campaign committed to sharing stories of hope in the face of illness thanks – in part...   Read More

Welcome news in two high-profile cancer battles

By Tina Stow  |    December 8, 2015
America’s biopharmaceutical companies are proud to be at the forefront of the battle against cancer, working tirelessly to develop innovative approaches for more effective treatments for...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates